These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29161469)

  • 1. Brief Report: Validation of a Definition of Flare in Patients With Established Gout.
    Gaffo AL; Dalbeth N; Saag KG; Singh JA; Rahn EJ; Mudano AS; Chen YH; Lin CT; Bourke S; Louthrenoo W; Vazquez-Mellado J; Hernández-Llinas H; Neogi T; Vargas-Santos AB; da Rocha Castelar-Pinheiro G; Amorim RBC; Uhlig T; Hammer HB; Eliseev M; Perez-Ruiz F; Cavagna L; McCarthy GM; Stamp LK; Gerritsen M; Fana V; Sivera F; Taylor W
    Arthritis Rheumatol; 2018 Mar; 70(3):462-467. PubMed ID: 29161469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a provisional definition of flare in patients with established gout.
    Gaffo AL; Schumacher HR; Saag KG; Taylor WJ; Dinnella J; Outman R; Chen L; Dalbeth N; Sivera F; Vázquez-Mellado J; Chou CT; Zeng X; Perez-Ruiz F; Kowalski SC; Goldenstein-Schainberg C; Chen L; Bardin T; Singh JA
    Arthritis Rheum; 2012 May; 64(5):1508-17. PubMed ID: 22083456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which factors predict discordance between a patient and physician on a gout flare?
    Jagpal A; Rahn EJ; Mudano AS; Dalbeth N; Taylor W; Saag KG; Singh JA; Cavagna L; Uhlig T; Perez-Ruiz F; McCarthy G; Gerritsen M; Stamp L; Vazquez Mellado J; Lin C; Vargas-Santos AB; Louthrenoo W; Neogi T; Chen YH; Castelar-Pinheiro GDR; Gaffo A
    Rheumatology (Oxford); 2021 Feb; 60(2):773-779. PubMed ID: 32793971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and First Validation of a Disease Activity Score for Gout.
    Scirè CA; Carrara G; Viroli C; Cimmino MA; Taylor WJ; Manara M; Govoni M; Salaffi F; Punzi L; Montecucco C; Matucci-Cerinic M; Minisola G;
    Arthritis Care Res (Hoboken); 2016 Oct; 68(10):1530-7. PubMed ID: 26815286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
    Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
    Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a valid definition of gout flare: results of consensus exercises using Delphi methodology and cognitive mapping.
    Taylor WJ; Shewchuk R; Saag KG; Schumacher HR; Singh JA; Grainger R; Edwards NL; Bardin T; Waltrip RW; Simon LS; Burgos-Vargas R
    Arthritis Rheum; 2009 Apr; 61(4):535-43. PubMed ID: 19333981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma D-dimer is a Promising Indicator for the Treatment of Acute Gouty Attack.
    Wu Y; Chu C; Song P; Yang Y; Lin C; Xu Q
    Ann Clin Lab Sci; 2018 Jul; 48(4):435-439. PubMed ID: 30143483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Postsurgical Gout Flares after Thoracolumbar Spine Surgeries.
    Chen KJ; Huang YC; Yao YC; Hsiung W; Chou PH; Wang ST; Chang MC; Lin HH
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of gout flare measurement.
    Stewart S; Dalbeth N; Gaffo A
    Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101716. PubMed ID: 34642108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a prediction model for inpatient gout flares in people with comorbid gout.
    Jatuworapruk K; Grainger R; Dalbeth N; Taylor WJ
    Ann Rheum Dis; 2020 Mar; 79(3):418-423. PubMed ID: 31811060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of the 2015 ACR-EULAR classification criteria for gout in a primary care population presenting with monoarthritis.
    Janssens HJEM; Fransen J; Janssen M; Neogi T; Schumacher HR; Jansen TL; Dalbeth N; Taylor WJ
    Rheumatology (Oxford); 2017 Aug; 56(8):1335-1341. PubMed ID: 28431109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How is symptom flare defined in musculoskeletal conditions: A systematic review.
    Costa N; Ferreira ML; Cross M; Makovey J; Hodges PW
    Semin Arthritis Rheum; 2018 Oct; 48(2):302-317. PubMed ID: 29496226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foot pain, impairment, and disability in patients with acute gout flares: A prospective observational study.
    Rome K; Frecklington M; McNair P; Gow P; Dalbeth N
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):384-8. PubMed ID: 22006512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GOSPEL 2 - Colchicine for the treatment of gout flares in France - a GOSPEL survey subgroup analysis. Doses used in common practices regardless of renal impairment and age.
    Pascart T; Lancrenon S; Lanz S; Delva C; Guggenbuhl P; Lambert C; Aubert JP; Saraux A; Ea HK; Lioté F
    Joint Bone Spine; 2016 Dec; 83(6):687-693. PubMed ID: 26919801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and construct validation of clinically relevant cutoffs on the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire.
    Myasoedova E; De Thurah A; Erpelding ML; Schneeberger EE; Maribo T; Citera G; Davis JM; Matteson EL; Crowson CS; Fautrel B; Guillemin F
    Semin Arthritis Rheum; 2020 Apr; 50(2):261-265. PubMed ID: 31526593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical activity measured using wearable activity tracking devices associated with gout flares.
    Elmagboul N; Coburn BW; Foster J; Mudano A; Melnick J; Bergman D; Yang S; Chen L; Filby C; Mikuls TR; Curtis JR; Saag K
    Arthritis Res Ther; 2020 Aug; 22(1):181. PubMed ID: 32746893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the KOFUS (Knee Osteoarthritis Flare-Ups Score).
    Marty M; Hilliquin P; Rozenberg S; Valat JP; Vignon E; Coste P; Savarieau B; Allaert FA
    Joint Bone Spine; 2009 May; 76(3):268-72. PubMed ID: 19297230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monosodium urate burden assessed with dual-energy computed tomography predicts the risk of flares in gout: a 12-month observational study : MSU burden and risk of gout flare.
    Pascart T; Grandjean A; Capon B; Legrand J; Namane N; Ducoulombier V; Motte M; Vandecandelaere M; Luraschi H; Godart C; Houvenagel E; Norberciak L; Budzik JF
    Arthritis Res Ther; 2018 Sep; 20(1):210. PubMed ID: 30223875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How flare prevention outcomes are reported in gout studies: A systematic review and content analysis of randomized controlled trials.
    Stewart S; Tallon A; Taylor WJ; Gaffo A; Dalbeth N
    Semin Arthritis Rheum; 2020 Apr; 50(2):303-313. PubMed ID: 31796212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The challenges of gout flare reporting: mapping flares during a randomized controlled trial.
    Teoh N; Gamble GD; Horne A; Taylor WJ; Palmano K; Dalbeth N
    BMC Rheumatol; 2019; 3():27. PubMed ID: 31334482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.